NOVEL SAPK ACTIVATING KINASE IN RENAL EPITHELIAL STRESS
NOVEL SAPK ACTIVATING KINASE IN RENAL EPITHELIAL STRESS
批准号:
2612865
负责人:
LAWRENCE B. HOLZMAN
金额:
$20.92万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2002-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Renal tubular epithelial injury results in dramatic cellular phenotypic
changes including alternations in morphology, cytoskeletal organization,
and induction of gene expression thought to be critical for regulating
the cell's early response to injury. Significant progress has been made
in defining the components and understanding the function of
intracellular signal transduction pathways that lead to regulation of
similar processes in other systems. The stress activated protein kinase
pathway and in particular SAPKs (stress activated protein kinases/c-jun
N-terminal kinases) are rapidly activated by multiple cell stressing
stimuli including ischemia/reperfusion induced injury of the kidney.
Moreover, the SAPKs are activated by GTP-bound Rac1 and Cdc42Hs, Rho-
like GTPases that were originally described as regulators of
cytoskeletal organization. Therefore, it has been proposed that
regulation of signal transduction pathways leading to SAPKs activation
may initiate part of the kidney's early response to injury. We have
identified, cloned from embryonic kidney, and initially characterized
a novel serine/threonine protein kinase called DLK. DLK is a member of
a structurally unique subfamily of protein kinases named mixed lineage
kinases.
As presented herein, DLK potently activates p46SAPK and p38 mapk but not
ERK2 when overexpressed in cell culture. DLK appears to participate as
a proximal activator of the SAPK pathway and may be a proximal effector
for Rac1 and Cdc42Hs. In normal adult kidney, DLK is expressed in the
proximal tubular epithelium where it is present only within a subapical
subcellular compartment. Given its localization within the kidney, its
ability to activate SAPK and p38mapk, and its potential role as an
effector of Rac1 and Cdc42Hs, we hypothesize that DLK represents a
proximal component of a signal transduction pathway or pathways that
participates in modulating the response of the tubular epithelium to
cellular stress or injury. This proposal seeks primarily to investigate
the fundamental biochemistry and regulation of DLK and will begin to
apply these findings to the proximal tubular epithelium. Specifically,
this project will: Specific Aim 1: Identify the specific downstream
substrate(s) of DLK and define the downstream pathway through which DLK
activates p46SAPK and p38 mapk. Specific Aim 2: Investigate the
regulation of DLK activity both by potential upstream stimuli and by
protein phosphatase 2B (calcineurin). Specific Aim 3: Investigate the
properties of DLK's leucine zipper domain and identify leucine zipper
domain interacting proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
-
批准号:9115603
-
项目类别:
-
资助金额:$98.02万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
-
批准号:8924248
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
-
批准号:8733166
-
项目类别:
-
资助金额:$101.6万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
CureGN-Penn PCC
-
批准号:10414798
-
项目类别:
-
资助金额:$105.46万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
CureGN-Penn PCC
-
批准号:10656280
-
项目类别:
-
资助金额:$104.68万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Primary Outcomes in Glomerulonephritis Study (PROGRESS)
-
批准号:8627364
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2013
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Pilot/Feasibility
-
批准号:10480859
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Career Enhancement
-
批准号:10480861
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Career Enhancement
-
批准号:10700988
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Slit Diaphragm and Actin Dynamics
-
批准号:8060605
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Career Enhancement
-
批准号:10017218
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Pilot/Feasibility
-
批准号:10700986
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Pilot/Feasibility
-
批准号:10251208
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Career Enhancement
-
批准号:10251209
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Slit Diaphragm and Actin Dynamics
-
批准号:8230613
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Slit Diaphragm and Actin Dynamics
-
批准号:7760671
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Training Program in Clinical & Translationa Research in Human Glomerular Disease
-
批准号:7937389
-
项目类别:
-
资助金额:$54.48万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Pilot/Feasibility
-
批准号:10017217
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2009
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Slit Diaphragm and Actin Dynamics
-
批准号:7985744
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2008
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
Slit Diaphragm and Actin Dynamics
-
批准号:7579979
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2008
-
负责人:LAWRENCE B. HOLZMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
-
批准号:JCZRQNB202600378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩小建
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
STING-Ca2+-Calcineurin 负反馈环在机体维
持抗病毒天然免疫稳态中的机制研究
-
批准号:Q24H100001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王宁
-
依托单位:
神经介素U通过NMUR1/calcineurin/NAFT 通路介导ARDS神经免疫环路调控的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:戚迪
-
依托单位:
神经分泌NMU通过NMUR1/calcineurin/NFAT通路调控ILC2介导的ARDS免疫炎症的效应及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王导新
-
依托单位:
Rcan2抑制Calcineurin活性决定尾鳍极性再生的机制研究
-
批准号:32170853
-
项目类别:面上项目
-
资助金额:57万元
-
批准年份:2021
-
负责人:陆辉强
-
依托单位:
Calcineurin/CRTC2轴介导的CD206+MerTK+巨噬细胞-肝细胞互作重塑移植肝糖稳态研究
-
批准号:82171757
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:凌琪
-
依托单位:
甲基转移酶 SETD2 调控 Calcineurin 信号抑制线粒体分裂在胶质母细胞瘤细胞增殖与侵袭中的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位: